Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine crossover study in severe obstructive sleep apnoea
ACTRN12617001481369Phase 3Completed
- Sponsor
- Prof. John R Wheatley
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Prof. John R Wheatley. Primary endpoint: Oxygen desaturation index. Started Jan 2018; status: completed.
02
Drugs
ketamine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12617001481369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001481369.